Recruiting

Observational Study

Sponsor:

Cedars-Sinai Medical Center

Code:

NCT02923752

Conditions

Ischemic Stroke

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MRI

Study Details

Brief summary:

This is a new vessel wall imaging-based stroke registry which will investigate the clinical utility of the whole-brain intracranial vessel wall Magnetic Resonance Imaging (MRI) technique in assessing the etiologies in patients with ischemic stroke.

Conditions

Ischemic Stroke

Study ID

NCT02923752

Start date

Feb 1, 2017

Status verified date

Aug, 2018

Completion date

Aug 1, 2019

Anticipated

Primary completion date

Aug 1, 2019

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Male or female ≥ 18 years of age
  • Ischemic stroke onset within 8 weeks and confirmed by diffusion weighted MRI
  • Ability to read and understand informed consent

Exclusion Criteria:

  • The cause of stroke has been confirmed to be related to cardiac or extracranial carotid or aorta pathologies.
  • Contraindications to MR imaging including mechanically, magnetically, or electrically activated implants, ferromagnetic implants and ferromagnetic foreign bodies, pregnancy.
  • Inability to tolerate MRI imaging secondary to an inability to lie supine or severe claustrophobia.
  • Non-compliant with visit instructions, including inability to lie still, hold breath or follow procedure instructions

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Interventions

MRI

Contrast-enhanced MRI

Primary outcome measure

  • Vessel wall pathology findings by MRI [ Time Frame: baseline ]

Central Contacts and Locations

Central contacts

Locations

Cedars-Sinai Medical Center

Recruiting

Los Angeles, California, United States, 90048

More Information

Sponsor

Cedars-Sinai Medical Center

Last update posted

Aug 14, 2018

Last verified

Aug, 2018

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Cedars-Sinai Medical Center on 2018-08-14.